Zevra Therapeutics (NASDAQ:ZVRA) PT Raised to $20.00

Zevra Therapeutics (NASDAQ:ZVRA – Get Free Report) had its target price lifted by equities research analysts at Canaccord Genuity Group from $19.00 to $20.00 in a research note issued on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target points to a potential upside of 305.68% […]

Related Keywords

United States , ,Canaccord Genuity Group ,Zevra Therapeutics Company Profile ,Zevra Therapeutics Inc ,Zevra Therapeutics ,Get Free Report ,Genuity Group ,Therapeutics Stock Down ,Ligand Activated Therapy ,Zevra Therapeutics Daily ,Nasdaq Zvra ,Zvra ,Medical ,Boost Price Target ,Canaccord Genuity Group Inc ,